166 related articles for article (PubMed ID: 36245230)
1. High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
Yazaki S; Kojima Y; Yoshida H; Takamizawa S; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Saito A; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Ohe Y; Yonemori K
J Gynecol Oncol; 2022 Nov; 33(6):e82. PubMed ID: 36245230
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract][Full Text] [Related]
3. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
4. Correlation of folate receptor alpha expression with clinicopathological parameters and outcome in triple negative breast cancer.
Zagorac I; Lončar B; Dmitrović B; Kralik K; Kovačević A
Ann Diagn Pathol; 2020 Oct; 48():151596. PubMed ID: 32829070
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor alpha is associated with cervical carcinogenesis and regulates cervical cancer cells growth by activating ERK1/2/c-Fos/c-Jun.
Liu C; Ding L; Bai L; Chen X; Kang H; Hou L; Wang J
Biochem Biophys Res Commun; 2017 Sep; 491(4):1083-1091. PubMed ID: 28782518
[TBL] [Abstract][Full Text] [Related]
6. High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study.
Takamizawa S; Yazaki S; Kojima Y; Yoshida H; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Yonemori K
BMC Cancer; 2022 Nov; 22(1):1215. PubMed ID: 36434635
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance.
Shia J; Klimstra DS; Nitzkorski JR; Low PS; Gonen M; Landmann R; Weiser MR; Franklin WA; Prendergast FG; Murphy L; Tang LH; Temple L; Guillem JG; Wong WD; Paty PB
Hum Pathol; 2008 Apr; 39(4):498-505. PubMed ID: 18342661
[TBL] [Abstract][Full Text] [Related]
8. Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging-guided lung cancer resections.
Azari F; Zhang K; Kennedy G; Bou-Samra P; Chang A; Nadeem B; Chang A; Galandarova A; Ibrahimli A; Karimov Z; Din A; Kucharczuk J; Doraid J; Pechet T; Delikatny E; Singhal S
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2453-2465. PubMed ID: 36905412
[TBL] [Abstract][Full Text] [Related]
9. Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.
Martin LP; Konner JA; Moore KN; Seward SM; Matulonis UA; Perez RP; Su Y; Berkenblit A; Ruiz-Soto R; Birrer MJ
Gynecol Oncol; 2017 Nov; 147(2):402-407. PubMed ID: 28843653
[TBL] [Abstract][Full Text] [Related]
10. Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma.
Cai L; Michelakos T; Ferrone CR; Zhang L; Deshpande V; Shen Q; DeLeo A; Yamada T; Zhang G; Ferrone S; Wang X
Oncotarget; 2017 Jun; 8(23):37646-37656. PubMed ID: 28430580
[TBL] [Abstract][Full Text] [Related]
11. Targeting folate receptor alpha for cancer treatment.
Cheung A; Bax HJ; Josephs DH; Ilieva KM; Pellizzari G; Opzoomer J; Bloomfield J; Fittall M; Grigoriadis A; Figini M; Canevari S; Spicer JF; Tutt AN; Karagiannis SN
Oncotarget; 2016 Aug; 7(32):52553-52574. PubMed ID: 27248175
[TBL] [Abstract][Full Text] [Related]
12. Folate receptor alpha as a tumor target in epithelial ovarian cancer.
Kalli KR; Oberg AL; Keeney GL; Christianson TJ; Low PS; Knutson KL; Hartmann LC
Gynecol Oncol; 2008 Mar; 108(3):619-26. PubMed ID: 18222534
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of folate receptor α-positive circulating tumour cells in gastric cancer.
Cao B; Liu L; Zhang R; Dong H; Shen J
Postgrad Med J; 2024 Jan; 100(1180):112-119. PubMed ID: 37973392
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance.
D'Angelica M; Ammori J; Gonen M; Klimstra DS; Low PS; Murphy L; Weiser MR; Paty PB; Fong Y; Dematteo RP; Allen P; Jarnagin WR; Shia J
Mod Pathol; 2011 Sep; 24(9):1221-8. PubMed ID: 21572402
[TBL] [Abstract][Full Text] [Related]
15. Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck.
Schnoell J; Jank BJ; Kadletz-Wanke L; Stoiber S; Gurnhofer E; Schlederer M; Heiduschka G; Kenner L
Onco Targets Ther; 2022; 15():531-538. PubMed ID: 35601979
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma.
Tamura N; Fujiwara Y; Hashimoto T; Shiraishi H; Kitano S; Shimizu T; Kuwano K; Yamamoto N; Motoi N
Lung Cancer; 2020 Jul; 145():152-157. PubMed ID: 32450493
[TBL] [Abstract][Full Text] [Related]
17. Folate Receptor α-Targeted
Heo GS; Detering L; Luehmann HP; Primeau T; Lee YS; Laforest R; Li S; Stec J; Lim KH; Lockhart AC; Liu Y
Mol Pharm; 2019 Sep; 16(9):3996-4006. PubMed ID: 31369274
[TBL] [Abstract][Full Text] [Related]
18. Exploiting the folate receptor α in oncology.
Scaranti M; Cojocaru E; Banerjee S; Banerji U
Nat Rev Clin Oncol; 2020 Jun; 17(6):349-359. PubMed ID: 32152484
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of FRα inhibits proliferation and promotes apoptosis of cervical cancer cells in vitro.
Bai LX; Ding L; Jiang SW; Kang HJ; Gao CF; Chen C; Zhou Q; Wang JT
Asian Pac J Cancer Prev; 2014; 15(14):5667-72. PubMed ID: 25081683
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.
Siu MK; Kong DS; Chan HY; Wong ES; Ip PP; Jiang L; Ngan HY; Le XF; Cheung AN
PLoS One; 2012; 7(11):e47201. PubMed ID: 23144806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
